Clinical Trial: Early Risk Stratification of Thyroid Eye Disease in Newly Diagnosed Graves' Disease

U.S., Sept. 11 -- ClinicalTrials.gov registry received information related to the study (NCT07812194) titled 'Early Risk Stratification of Thyroid Eye Disease in Newly Diagnosed Graves' Disease' on Aug. 26.

Brief Summary: The aim of this observational study is to investigate why some people with newly diagnosed Graves' disease (GD) develop thyroid eye disease (TED), also known as Graves' orbitopathy, while others do not.

The main questions the study aims to answer are:

1. What proportion of participants develop TED within one year of being diagnosed with GD?

2. Which early clinical signs, ophthalmological findings, blood biomarkers, tear-fluid biomarkers, or ocular surface microbiome characteristics are associated with an increased risk...